You Searched For "first pharmaceutical firm" and got 20 results
Sort By:
4 mins read
The free market doesn't care if you live or die: How Big Pharma left the world vulnerable to coronavirus
Coronavirus was the final exam for the free market healthcare system, and now the experiment is ove…
Paul Constant
2 mins read
French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline
Sanofi, one of the world's biggest pharmaceutical companies, has invested €50 million in new French…
Theo Golden,Dr. Catherine Sch…
1 min read
27 pharma execs involved in the hunt for COVID-19 vaccines have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most from Regeneron, Moderna, Vir, and more.
A Business Insider analysis found 27 biotech insiders who had cashed in more than $10 million in st…
Andrew Dunn
3 mins read
Pfizer will start testing its coronavirus vaccine on children as young as 12, a crucial step to bringing the shot to more people
So far, coronavirus vaccine trials have focused on adults. One of the leading drugmakers is now ope…
Andrew Dunn
3 mins read
Trump's experimental treatment from Regeneron puts the company in a 'very tough situation' as others request early access, CEO says
Trump was given early access to the experiment drug through "compassionate use," which requires bot…
Evan Sully
2 mins read
Top stocks to watch today— RIL, Wipro, Future Retail, Infosys, ICICI Bank and more
Amid mixed cues from the global market, Indian stock-market indices are likely to open on a negativ…
1 min read
Glenmark Pharmaceuticals shares soar 20 pc after COVID-19 drug launch
The drug firm on Saturday said it has launched antiviral drug FabiFlu for the treatment of patient…
PTI
1 min read
Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall
Regeneron's antibody cocktail COVID-19 treatment is set to begin clinical trials over the summer, w…
Carmen Reinicke
2 mins read
Zydus Cadila begins human clinical trials of COVID-19 vaccine candidate
The adaptive phase I/ II human clinical trials of ZyCoV-D have commenced with the first human d…
PTI
3 mins read
Cipla only Indian firm to bid for Kremers Urban Pharmaceuticals Inc.
The previous year’s report has said that Kremers Urban Pharmaceuticals Inc had sales of $463 millio…
1 min read
Balenciaga has become one of the first major fashion brands to leave Twitter amid concern over Elon Musk's takeover
Balenciaga confirmed to Vogue the company's Twitter account was removed but did not comment on the …
Beatrice Nolan
2 mins read
Experts believe COVID-19 vaccine doses need a at least a 21-day gap between them
As India gets readied for a massive Covid vaccination programme, heath experts on Sunday said that …
3 mins read
Verily just presented for the first time at JPMorgan's big health conference. Here's how the CEO of Alphabet's life sciences firm laid out the unusual business to top investors.
He was speaking in the company's first-ever presentation on the stage at the biggest healthcare con…
Lydia Ramsey
5 mins read
Pharmaceuticals: Going Large
As biologics increase their market share, their cost and efficacy will come under greater scrutiny.…
4 mins read
Apps and video games are changing the way we treat diseases. Experts say they're prime M&A targets for telehealth firms.
Digital therapeutics are apps and video games that treat health conditions. But they need a savvy b…
Allison DeAngelis
2 mins read
Indian American's US pharma firm donates 3.4 M Hydroxychloroquine Sulphate tablets
Owned by philanthropic billionaire Chirag and Chintu Patel, New Jersey-based Amneal Pharmaceutical…
PTI
5 mins read
Photo Essay: As we celebrate the first malaria vaccine, remembering the epidemic's staggering toll
Photographer Diana Zeyneb Alhindawi documented the malaria epidemic's toll during one of the worst …
Diana Zeyneb Alhindawi
3 mins read
This VC firm invested in Pharmeasy when it was valued at just $10 million – here’s why it promises to invest in every round even after an IPO
Pharmeasy was one of the startups that got a billion dollar valuation in the unicorn frenzy, where …
4 mins read
The FDA just approved the first new Alzheimer's drug in 18 years
The Food and Drug Administration approved Biogen's Alzheimer's disease treatment even though outsid…
Allison DeAngelis
3 mins read
The CEO of pharmaceutical giant Merck is a Harvard-trained lawyer, and he shares what attorneys need to do to be 'treated as the wise people in the room' again
Pressure to specialize in one area, like trial law, had already started to build. But upon his arri…